Dr. Asha Shah, Stamford Health Director of Infectious Diseases, joined Yahoo Finance to discuss the latest on covid-19.
Vaccinating the world against the coronavirus is a lucrative business, and the shifting winds of the pandemic have big implications for the competitive landscape of vaccine makers. The principal reason why the vaccine landscape is changing is that some of the products on the market seem to be more effective against the delta variant than others. The two-dose jabs made by Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) remain the gold standard for generating durable immunity against the coronavirus.
Dr. Susannah Hills, Pediatric Airway Surgeon and Assistant Professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.